Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

The Scientific World Journal
Volume 2012, Article ID 381434, 21 pages
http://dx.doi.org/10.1100/2012/381434
Review Article

The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer

1Research Laboratory on Neuropeptides, Hospital Infantil Universitario Virgen del Rocío, Avenida Manuel Siurot s/n, 41013 Seville, Spain
2Department of Pediatric Infectious Diseases and Immunology, Hospital Infantil Universitario Virgen del Rocío, Avenida Manuel Siurot s/n, 41013 Seville, Spain
3Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Lindwurmstrasse 4, 80337 Munich, Germany

Received 29 October 2011; Accepted 20 November 2011

Academic Editors: D. A. Altomare and A. K. Kiemer

Copyright © 2012 Marisa Rosso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [31 citations]

The following is the list of published articles that have cited the current article.

  • Marisa Rosso, “The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer (vol 2012, 381434, 2012),” Scientific World Journal, 2012. View at Publisher · View at Google Scholar
  • Kiyoshi Misawa, Takeharu Kanazawa, Yuki Misawa, Atsushi Imai, Takayuki Uehara, Daiki Mochizuki, Shiori Endo, Goro Takahashi, and Hiroyuki Mineta, “Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer,” Journal Of Cancer Research And Clinical Oncology, vol. 139, no. 5, pp. 879–889, 2013. View at Publisher · View at Google Scholar
  • Vinay Kant, Anu Gopal, Dhirendra Kumar, Sadhan Bag, Nitin P. Kurade, Amit Kumar, Surendra K. Tandan, and Dinesh Kumar, “Topically applied substance P enhanced healing of open excision wound in rats,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Ming Shi, Dan Liu, Zhengyan Yang, and Ning Guo, “Central and peripheral nervous systems: master controllers in cancer metastasis,” Cancer and Metastasis Reviews, vol. 32, no. 3-4, pp. 603–621, 2013. View at Publisher · View at Google Scholar
  • Elizabeth N. Madva, and Richard D. Granstein, “Nerve-derived transmitters including peptides influence cutaneous immunology,” Brain Behavior and Immunity, vol. 34, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Christine Rangger, Anna Helbok, Jane Sosabowski, Christian Kremser, Gottfried Koehler, Ruth Prassl, Fritz Andreae, Irene J. Virgolini, Elisabeth von Guggenberg, and Clemens Decristoforo, “Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles,” International Journal of Nanomedicine, vol. 8, pp. 4659–4670, 2013. View at Publisher · View at Google Scholar
  • Jakob Evers, Nick A. Bersinger, Michael D. Mueller, and Brett D. McKinnon, “Induction of the Neurokinin 1 Receptor by TNF alpha in Endometriotic Tissue Provides the Potential for Neurogenic Control Over Endometriotic Lesion Growth,” Journal Of Clinical Endocrinology & Metabolism, vol. 98, no. 6, pp. 2469–2477, 2013. View at Publisher · View at Google Scholar
  • Elizabeth Harford-Wright, Kate M. Lewis, Mounir N. Ghabriel, and Robert Vink, “Treatment with the NK1 Antagonist Emend Reduces Blood Brain Barrier Dysfunction and Edema Formation in an Experimental Model of Brain Tumors,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • J. F. Borrego, M. K. Huelsmeyer, M. E. Pinkerton, J. L. Muszynski, S. A. K. Miller, I. D. Kurzman, and D. M. Vail, “Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues,” Veterinary and Comparative Oncology, vol. 14, no. 2, pp. 210–224, 2014. View at Publisher · View at Google Scholar
  • Fabio Bignami, Chiara Giacomini, Anna Lorusso, Andrea Aramini, Paolo Rama, and Giulio Ferrari, “NK1 Receptor Antagonists as a New Treatment for Corneal Neovascularization,” Investigative Ophthalmology & Visual Science, vol. 55, no. 10, 2014. View at Publisher · View at Google Scholar
  • Gizelle Robinson, Dana Most, Laura B. Ferguson, Jody Mayfield, R. Adron Harris, and Yuri A. Blednov, “Neuroimmune Pathways in Alcohol Consumption: Evidence from Behavioral and Genetic Studies in Rodents and Humans,” Neuroimmune Signaling in Drug Actions and Addictions, vol. 118, pp. 13–39, 2014. View at Publisher · View at Google Scholar
  • Margit Pissarek, “Neuropeptide Receptors in Pain Circuitries: Useful Targets for CNS Imaging with Non-Peptide Ligands Suitable for PET?,” World Journal of Neuroscience, vol. 04, no. 04, pp. 353–383, 2014. View at Publisher · View at Google Scholar
  • Takeharu Kanazawa, Kiyoshi Misawa, Yuki Misawa, Takayuki Uehara, Hirofumi Fukushima, Gen Kusaka, Mikiko Maruta, and Thomas E. Carey, “G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?,” Toxins, vol. 7, no. 8, pp. 2959–2984, 2015. View at Publisher · View at Google Scholar
  • Agnes Garnier, Jody Vykoukal, Jochen Hubertus, Eckhard Alt, Dietrich Von Schweinitz, Roland Kappler, Michael Berger, and Matthias Ilmer, “Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells,” International Journal Of Oncology, vol. 47, no. 1, pp. 151–160, 2015. View at Publisher · View at Google Scholar
  • Imène Chaïr-Yousfi, Fatima Laraba-Djebari, and Djelila Hammoudi-Triki, “Androctonus australis hector venom contributes to the interaction between neuropeptides and mast cells in pulmonary hyperresponsiveness,” International Immunopharmacology, vol. 25, no. 1, pp. 19–29, 2015. View at Publisher · View at Google Scholar
  • Matthias Ilmer, Agnes Garnier, Jody Vykoukal, Eckhard Alt, Dietrich von Schweinitz, Roland Kappler, and Michael Berger, “Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma,” Molecular Cancer Therapeutics, vol. 14, no. 12, pp. 2712–2721, 2015. View at Publisher · View at Google Scholar
  • Alejandra N. Martinez, Geeta Ramesh, Mary B. Jacobs, and Mario T. Philipp, “Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis,” Journal of Neuroinflammation, vol. 12, no. 1, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Qingshan Wang, Esteban Oyarzabal, Belinda Wilson, Li Qian, and Jau-Shyong Hong, “Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in mice,” Clinical Science, vol. 129, no. 8, pp. 757–767, 2015. View at Publisher · View at Google Scholar
  • Ananda Kumar Kanduluru, Madduri Srinivasarao, and Philip S. Low, “Design, Synthesis, and Evaluation of a Neurokinin-1 Receptor-Targeted Near-IR Dye for Fluorescence-Guided Surgery of Neuroendocrine Cancers,” Bioconjugate Chemistry, 2016. View at Publisher · View at Google Scholar
  • Jaspreet Kaur, Shweta Sharma, Manpreet Sandhu, and Saurabh Sharma, “Neurokinin-1 receptor inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: possible mechanisms,” Inflammopharmacology, 2016. View at Publisher · View at Google Scholar
  • Wenjiao Zheng, Junling Wang, Wei Zhu, Chiyan Xu, and Shaoheng He, “Upregulated expression of substance P in basophils of the patients with chronic spontaneous urticaria: induction of histamine release and basophil accumulation by substance P,” Cell Biology and Toxicology, 2016. View at Publisher · View at Google Scholar
  • Samaneh Bayati, Shahin Ahmadian, Ava Safaroghli-Azar, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Seyed H. Ghaffari, and Davood Bashash, “Inhibition of tachykinin NK1 receptor using aprepitant induces apoptotic cell death and G1 arrest through Akt/p53 axis in pre-B acute lymphoblastic leukemia cells,” European Journal of Pharmacology, vol. 791, pp. 274–283, 2016. View at Publisher · View at Google Scholar
  • Agnès Garnier, Roland Kappler, Michael Berger, and Matthias Ilmer, “Therapeutic innovations for targeting hepatoblastoma,” Anticancer Research, vol. 36, no. 11, pp. 5577–5592, 2016. View at Publisher · View at Google Scholar
  • Agnes Garnier, Matthias Ilmer, Kristina Becker, Beate Haeberle, Dietrich Von Schweinitz, Roland Kappler, and Michael Berger, “Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage,” Oncology Letters, vol. 11, no. 1, pp. 870–878, 2016. View at Publisher · View at Google Scholar
  • Zenan Zhang, Wenjiao Zheng, Hua Xie, Ruonan Chai, Junling Wang, Huiyun Zhang, and Shaoheng He, “Up-regulated expression of substance P in CD8+ T cells and NK1R on monocytes of atopic dermatitis,” Journal of Translational Medicine, vol. 15, no. 1, 2017. View at Publisher · View at Google Scholar
  • Mengmeng Zhan, Wenjiao Zheng, Qijun Jiang, Zuotao Zhao, Zhiyun Wang, Junling Wang, Huiyun Zhang, and Shaoheng He, “Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation,” Cell Biology and Toxicology, 2017. View at Publisher · View at Google Scholar
  • Chia-Mei Chou, Yueh-Lun Lee, Chien-Wei Liao, Ying-Chieh Huang, and Chia-Kwung Fan, “Enhanced expressions of neurodegeneration-associated factors, UPS impairment, and excess Aβ accumulation in the hippocampus of mice with persistent cerebral toxocariasis,” Parasites & Vectors, vol. 10, no. 1, 2017. View at Publisher · View at Google Scholar
  • Ananda Kumar Kanduluru, and Philip S. Low, “Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers,” Molecular Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Nimmi Baby, Kumar Krishna, Muhammad Hakim, Yuk Peng Wong, Thomas Behnisch, Tuck Wah Soong, Sreedharan Sajikumar, and Ananya Dasgupta, “Substance P induces plasticity and synaptic tagging/capture in rat hippocampal area CA2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 41, pp. E8741–E8749, 2017. View at Publisher · View at Google Scholar
  • Xia Gao, and Zhenjun Wang, “Difference in expression of two neurokinin-1 receptors in adenoma and carcinoma from patients that underwent radical surgery for colorectal carcinoma,” Oncology Letters, vol. 14, no. 3, pp. 3729–3733, 2017. View at Publisher · View at Google Scholar
  • Joylee Fernandes, Jayesh Mudgal, Chamallamudi Mallikarjuna Rao, Devinder Arora, Sanchari Basu Mallik, K. S. R. Pai, and Madhavan Nampoothiri, “N-acetyl-L-tryptophan, a substance-P receptor antagonist attenuates aluminum-induced spatial memory deficit in rats,” Toxicology Mechanisms and Methods, vol. 28, no. 5, pp. 328–334, 2018. View at Publisher · View at Google Scholar